CVE-2021-1383

Public Exploit
Cisco IOS XE SD-WAN Software Parameter Injection Vulnerabilities

Description

Multiple vulnerabilities in the CLI of Cisco IOS XE SD-WAN Software could allow an authenticated, local attacker to access the underlying operating system with root privileges. These vulnerabilities are due to insufficient input validation of certain CLI commands. An attacker could exploit these vulnerabilities by authenticating to the device and submitting crafted input to the CLI. The attacker must be authenticated as an administrative user to execute the affected commands. A successful exploit could allow the attacker to access the underlying operating system with root privileges.

Categories

6.0
CVSS
Severity: Medium
CVSS 3.1 •
CVSS 2.0 •
EPSS 0.15%
Vendor Advisory cisco.com
Affected: Cisco Cisco IOS XE Software
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2021-1383?
CVE-2021-1383 has been scored as a medium severity vulnerability.
How to fix CVE-2021-1383?
To fix CVE-2021-1383, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2021-1383 being actively exploited in the wild?
It is possible that CVE-2021-1383 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2021-1383?
CVE-2021-1383 affects Cisco Cisco IOS XE Software.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.